The cancer associated antigen test as an index to failure of complete removal of urological cancers.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis*; D001666:Binding Sites, Antibody; D004407:Dysgerminoma / Q000276:immunology; D005260:Female; D006041:Goats; D006801:Humans; D007106:Immune Sera; D007680:Kidney Neoplasms / Q000276:immunology; D008297:Male; D008403:Mass Screening; D008722:Methods; D010412:Penile Neoplasms / Q000276:immunology; D010673:Pheochromocytoma / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology; D011863:Radioimmunoassay; D013724:Teratoma / Q000276:immunology; D013736:Testicular Neoplasms / Q000276:immunology; D014516:Ureteral Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology*; D014570:Urologic Diseases / Q000276:immunology; D009396:Wilms Tumor / Q000276:immunology
D000951:Antigens, Neoplasm; D007106:Immune Sera